Ivonescimab and ADG126, Alone, and in Combination With Leucovorin and Fluorouracil or FOLFIRI Regimen for the Treatment of Microsatellite Stable Advanced/Metastatic Colorectal Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Ivonescimab
Related studies linked through entity extraction aliases.
Testing Ivonescimab in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancers Without Liver Metastases
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Mechanism of Enhanced Efficacy of Ivonescimab in Neoadjuvant Therapy for Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- N/A
Glecirasib Combined With Ivonescimab for First-line Treatment of KRAS G12C-mutated NSCLC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Ivonescimab in First-Line ES-SCLC
- Status
- RECRUITING
- Phase
- PHASE2
Phase II Study of Upfront SRT Plus Ivonescimab/Chemotherapy vs Ivonescimab/Chemotherapy in NSCLC Brain Mets
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Trial Evaluating the Efficacy of Ivonescimab in Metastatic Endocrine Refractory HR-positive HER2-negative or Triple Negative Invasive Lobular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Ivonescimab Prior to Surgery for the Treatment of High-Risk Localized Clear Cell Renal Cell Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study of YL201 and Ivonescimab (AK112) in Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
The IVO-LUNG Study
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Ivonescimab Before Surgery for the Treatment of Resectable Stage II-IV Head and Neck Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Combination Therapy for PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma: A Bayesian Adaptive Phase II Trial
- Status
- RECRUITING
- Phase
- PHASE2
Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA
- Status
- RECRUITING
- Phase
- PHASE2
STRIVE: A Single-arm Phase 2 Study on Treatment of Lung Squamous Cell Carcinoma by Tiragolumab Plus Ivonescimab for Patients Who Progressed on Platinum Doublets and Anti-PD-1/PD-L1
- Status
- WITHDRAWN
- Phase
- PHASE2
Phase II Trial of Ivonescimab in Combination With Carboplatin + Docetaxel in Patients With Early-Stage Triple Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Ivonescimab for the Treatment of Thymic Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Neoadjuvant Therapy With Ivonescimab Combined With Chemotherapy for Triple-Negative Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Phase II Study of Anti-PD-1/VEGF Bispecific Antibody Ivonescimab in Patients With Previously Treated Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
ctDNA-MRD Guided Escalation of Ivonescimab and Docetaxel in Advanced NSCLC With Long-Term Responses to First-line Immunotherapy (CR1STAL-Adaptive)
- Status
- RECRUITING
- Phase
- PHASE2
Phase II Trial of Ivonescimab in Previously Treated Patients With Advanced Clear Cell Renal Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2